Common use

Nocdurna (desmopressin acetate) is a synthetic analogue of the natural antidiuretic hormone vasopressin, prescribed specifically for the treatment of nocturia due to nocturnal polyuria in adults. Nocturia — the need to wake up multiple times during the night to urinate — significantly disrupts sleep quality, impairs daytime functioning, and reduces overall quality of life. Desmopressin works by mimicking vasopressin's action on the V2 receptors in the kidneys, which increases water reabsorption from the collecting ducts back into the bloodstream. This reduces the volume of urine produced during the night, allowing patients to enjoy longer periods of uninterrupted sleep. Nocdurna is available as a sublingual (under-the-tongue) tablet formulation specifically designed for this indication. Buy Nocdurna online at dutypills.ovh for affordable nocturia treatment with fast, discreet delivery.

Dosage and direction

Nocdurna is taken once daily, approximately one hour before bedtime. The sublingual tablet should be placed under the tongue and allowed to dissolve completely — do not swallow it whole, chew, or take it with water. The recommended dose differs by sex: 25 mcg for women and 50 mcg for men, reflecting gender-based differences in fluid regulation. Dosage is individually optimized based on age, kidney function, serum sodium levels, and clinical response. To minimize the risk of hyponatremia (dangerously low blood sodium), fluid intake must be restricted starting at least 1 hour before taking the tablet and throughout the entire night until the next morning (at least 8 hours). Follow your healthcare provider's instructions carefully regarding both dosing and fluid management.

Precautions

Before starting Nocdurna, inform your doctor if you have kidney disease or impaired renal function, heart failure or cardiovascular disease, a history of hyponatremia (low blood sodium), polydipsia (excessive thirst) or habitual excessive fluid intake, syndrome of inappropriate ADH secretion (SIADH), or if you take diuretics, corticosteroids, or other medications that affect fluid and electrolyte balance. Serum sodium levels must be measured before starting treatment, within 3 days and 7 days after initiation, one month after starting, and periodically thereafter. Discontinue Nocdurna if serum sodium falls below 135 mmol/L or if symptoms of hyponatremia develop (headache, nausea, confusion, lethargy, weakness, muscle cramps). Elderly patients (over 65) are particularly susceptible to hyponatremia and require close monitoring. Strictly adhere to fluid restriction guidelines to prevent water intoxication.

Contraindications

Do not use Nocdurna if you are allergic to desmopressin or any component of the sublingual tablet formulation. It is contraindicated in patients with primary or psychogenic polydipsia (excessive fluid intake), cardiac insufficiency requiring diuretic therapy, moderate to severe kidney impairment (eGFR below 50 mL/min), known or suspected hyponatremia (serum sodium below 135 mmol/L), SIADH (syndrome of inappropriate antidiuretic hormone secretion), or conditions requiring treatment with loop diuretics.

Possible side effect

Common side effects of Nocdurna include headache, nausea, mild abdominal discomfort, dry mouth, dizziness, and peripheral edema (swelling of hands, ankles, or feet). Serious side effects requiring immediate medical attention include hyponatremia — the most significant risk — which can manifest as severe headache, nausea, vomiting, confusion, lethargy, disorientation, restlessness, muscle weakness, cramps, seizures, or in severe cases, loss of consciousness and coma. Water intoxication (fluid overload) may also occur if fluid restriction is not followed. Rapid weight gain, significantly decreased urine output, or low blood pressure episodes should be reported promptly to your doctor.

Drug interaction

Nocdurna may interact with loop diuretics (furosemide — concomitant use is contraindicated), thiazide diuretics, corticosteroids (may increase hyponatremia risk), carbamazepine and oxcarbazepine (which enhance desmopressin's antidiuretic effect and increase hyponatremia risk), SSRIs, SNRIs, tricyclic antidepressants, chlorpromazine, NSAIDs (ibuprofen, naproxen — may increase water retention), and loperamide (may increase desmopressin absorption). Inform your doctor about all prescription drugs, over-the-counter products, vitamins, and supplements you are taking.

Missed dose

If a dose is missed, skip it entirely and continue with your usual schedule the next evening before bedtime. Do not take two doses in one night or take a dose during daytime hours, as this could increase the risk of hyponatremia.

Overdose

Overdose of desmopressin may cause excessive water retention and severe hyponatremia, leading to headache, nausea, vomiting, confusion, drowsiness, muscle weakness, seizures, or loss of consciousness. Seek immediate emergency medical attention if overdose is suspected. Treatment involves fluid restriction, careful monitoring and correction of serum sodium levels, and supportive care. In severe cases, intravenous hypertonic saline may be required under close medical supervision.

Storage

Store Nocdurna at controlled room temperature between 68°F and 77°F (20°C to 25°C), away from heat, moisture, and direct light. Keep sublingual tablets in their original blister packaging until ready to use. Handle with dry hands only. Store securely out of the reach of children and pets.

Disclaimer

We provide only general information about medications which does not cover all directions, possible drug integrations, or precautions. Information at the site cannot be used for self-treatment and self-diagnosis. Any specific instructions for a particular patient should be agreed with your health care adviser or doctor in charge of the case. We disclaim reliability of this information and mistakes it could contain. We are not responsible for any direct, indirect, special or other indirect damage as a result of any use of the information on this site and also for consequences of self-treatment.